| Hormonal Regulation and Hypertension | Lifetime | 19 | US 8 | 99.76 |
| Apelin-related biomedical research | Lifetime | 7 | US 2 | 99.32 |
| Blood Pressure and Hypertension Studies | Lifetime | 47 | US 22 | 99.76 |
| Pharmacology and Obesity Treatment | Lifetime | 14 | US 8 | 99.65 |
| Diet and metabolism studies | Lifetime | 132 | US 62 | 99.66 |
| Adipose Tissue and Metabolism | Lifetime | 120 | US 61 | 99.61 |
| Diet, Metabolism, and Disease | Lifetime | 85 | US 39 | 99.34 |
| Metabolism, Diabetes, and Cancer | Lifetime | 109 | US 53 | 99.45 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 100 | US 51 | 99.41 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 20 | US 3 | 99.03 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 107 | US 48 | 99.50 |
| Diabetes Treatment and Management | Lifetime | 127 | US 60 | 99.44 |
| Cardiovascular Function and Risk Factors | Lifetime | 245 | US 147 | 99.52 |
| Sodium Intake and Health | Lifetime | 32 | US 16 | 99.21 |
| Heart Rate Variability and Autonomic Control | Lifetime | 235 | US 111 | 98.98 |
| Cardiovascular Disease and Adiposity | Lifetime | 152 | US 87 | 99.14 |
| Renin-Angiotensin System Studies | Lifetime | 68 | US 26 | 98.99 |
| Cardiovascular Health and Disease Prevention | Lifetime | 218 | US 103 | 98.80 |
| Nitric Oxide and Endothelin Effects | Lifetime | 250 | US 126 | 98.83 |
| Birth, Development, and Health | Lifetime | 729 | US 284 | 98.06 |
| Chronic Kidney Disease and Diabetes | Lifetime | 281 | US 129 | 98.42 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 581 | US 258 | 97.47 |
| Electrolyte and hormonal disorders | Lifetime | 340 | US 156 | 96.83 |
| Renal function and acid-base balance | Lifetime | 344 | US 172 | 96.49 |
| Lipoproteins and Cardiovascular Health | Lifetime | 820 | US 345 | 96.88 |
| Hormonal and reproductive studies | Lifetime | 855 | US 396 | 96.40 |
| Advanced Glycation End Products research | Lifetime | 429 | US 118 | 94.91 |
| Regulation of Appetite and Obesity | Lifetime | 801 | US 352 | 95.80 |
| Adrenal Hormones and Disorders | Lifetime | 603 | US 228 | 94.46 |
| Ion Transport and Channel Regulation | Lifetime | 734 | US 352 | 94.43 |
| Hormonal Regulation and Hypertension | 2021-2025 | 177 | US 46 | 93.56 |
| Apelin-related biomedical research | 2021-2025 | 24 | US 7 | 89.27 |
| Sodium Intake and Health | 2021-2025 | 407 | US 96 | 75.37 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 164 | US 21 | 70.62 |
